P. Casajust

发表

Current Approaches to Vaccine Safety Using Observational Data: A Rationale for the EUMAEUS (Evaluating Use of Methods for Adverse Events Under Surveillance-for Vaccines) Study Design

M. Suchard, M. Schuemie, N. Pratt, 2022, Frontiers in Pharmacology.

Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study

G. Hripcsak, M. Matheny, C. Lambert, 2020, medRxiv.

Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study

George Hripcsak, Jenna Reps, Rupa Makadia, 2020, The Lancet Rheumatology.

Risk of depression, suicidal ideation, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multi-national network cohort study

M. Suchard, G. Hripcsak, J. Banda, 2020, medRxiv.

Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study

M. Suchard, S. Lovestone, G. Hripcsak, 2020, Rheumatology.

Can we trust the prediction model? Demonstrating the importance of external validation by investigating the COVID-19 Vulnerability (C-19) Index across an international network of observational healthcare datasets

M. Suchard, E. Steyerberg, S. Liaw, 2020, medRxiv.

Baseline characteristics, management, and outcomes of 55,270 children and adolescents diagnosed with COVID-19 and 1,952,693 with influenza in France, Germany, Spain, South Korea and the United States: an international network cohort study

Andrew E. Williams, M. Suchard, N. Shah, 2020, medRxiv.

Characteristics and outcomes of 627 044 COVID-19 patients with and without obesity in the United States, Spain, and the United Kingdom

N. Shah, P. Ryan, C. Reich, 2020, medRxiv.

Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including >3.32 million people tested with real-time PCR and >219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United States

Jason A. Thomas, Andrew E. Williams, M. Suchard, 2020, medRxiv.

Use of dialysis, tracheostomy, and extracorporeal membrane oxygenation among 842,928 patients hospitalized with COVID-19 in the United States

M. Suchard, N. Shah, J. Jonnagaddala, 2020, medRxiv.

Empagliflozin reduces cardiorenal events, healthcare resource use and mortality in Sweden compared to dipeptidyl peptidase‐4 inhibitors: Real world evidence from the Nordic EMPRISE study

J. Skogsberg, P. Casajust, T. Nyström, 2022, Diabetes, obesity & metabolism.

Thirty-Day Outcomes of Children and Adolescents With COVID-19: An International Experience

Andrew E. Williams, M. Suchard, N. Shah, 2021, Pediatrics.

Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study

M. Suchard, N. Shah, J. Jonnagaddala, 2021, BMJ.

Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS

Jason A. Thomas, Andrew E. Williams, M. Suchard, 2022, Clinical epidemiology.

Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS

Andrew E. Williams, M. Suchard, N. Shah, 2021, Research square.

Heterogeneity and temporal variation in the management of COVID-19: a multinational drug utilization study including 71,921 hospitalized patients from China, South Korea, Spain, and the United States of America

Andrew E. Williams, M. Suchard, J. Jonnagaddala, 2020, medRxiv.

Bias, Precision and Timeliness of Historical (Background) Rate Comparison Methods for Vaccine Safety Monitoring: An Empirical Multi-Database Analysis

M. Suchard, M. Schuemie, N. Pratt, 2021, Frontiers in Pharmacology.

Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom

N. Shah, C. Reich, M. Matheny, 2021, International Journal of Obesity.

COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries

M. Suchard, N. Shah, J. Jonnagaddala, 2021, Rheumatology.

Can we trust the prediction model? Illustrating the importance of external validation by implementing the COVID-19 Vulnerability (C-19) Index across an international network of observational healthcare datasets.

Ross D. Williams, Andrew E. Williams, M. Suchard, 2021, JMIR medical informatics.

Implementation of the COVID-19 Vulnerability Index Across an International Network of Health Care Data Sets: Collaborative External Validation Study

Ross D. Williams, Andrew E. Williams, M. Suchard, 2020, JMIR Medical Informatics.

Clinical characteristics, symptoms, management and health outcomes in 8,598 pregnant women diagnosed with COVID-19 compared to 27,510 with seasonal influenza in France, Spain and the US: a network cohort analysis

M. Suchard, N. Shah, J. Jonnagaddala, 2020, medRxiv.

Characteristics and outcomes of COVID-19 patients with and without asthma from the United States, South Korea, and Europe

M. Suchard, N. Shah, K. Verhamme, 2022, The Journal of asthma : official journal of the Association for the Care of Asthma.

Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and Spain

M. Suchard, N. Shah, I. Soerjomataram, 2021, Cancer Epidemiology, Biomarkers & Prevention.

Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysis

M. Suchard, N. Shah, J. Jonnagaddala, 2020, medRxiv.

Characteristics and outcomes of 118,155 COVID-19 individuals with a history of cancer in the United States and Spain

N. Shah, I. Soerjomataram, J. Jonnagaddala, 2021, medRxiv.

Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia

L. Niskanen, K. Khunti, M. Nangaku, 2023, Cardiovascular Diabetology.